ABBV vs SAVA

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Cassava Sciences continues to face an existential crisis due to unresolved allegations of data manipulation and ongoing regulatory investigations by the FDA and NIH concerning its lead drug candidate, simufilam. While the Alzheimer's market offers theoretical 10x growth potential, this is fundamentally undermined by a profound trust deficit in leadership and the scientific integrity of their core ...